365 related articles for article (PubMed ID: 18664967)
1. Prevention of venous thromboembolism after ischemic stroke.
Kase CS; Pineo GF
Curr Opin Pulm Med; 2008 Sep; 14(5):389-96. PubMed ID: 18664967
[TBL] [Abstract][Full Text] [Related]
2. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.
Vergouwen MD; Roos YB; Kamphuisen PW
Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676
[TBL] [Abstract][Full Text] [Related]
4. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin for thromboprophylaxis.
Camporese G; Bernardi E
Curr Opin Pulm Med; 2009 Sep; 15(5):443-54. PubMed ID: 19593139
[TBL] [Abstract][Full Text] [Related]
6. Successors to heparin: new antithrombotic agents.
Turpie AG
Am Heart J; 1997 Nov; 134(5 Pt 2):S71-7. PubMed ID: 9396637
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparins in the treatment of unstable angina.
Ageno W; Turpie AG
Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
[TBL] [Abstract][Full Text] [Related]
8. From unfractionated heparins to low molecular weight heparins.
Hirsh J
Acta Chir Scand Suppl; 1990; 556():42-50. PubMed ID: 1705072
[TBL] [Abstract][Full Text] [Related]
9. Letters on management of ischemic stroke.
Porat G
Am Fam Physician; 2012 Sep; 86(6):492. PubMed ID: 23062038
[No Abstract] [Full Text] [Related]
10. Bemiparin: second-generation, low-molecular-weight heparin for treatment and prophylaxis of venous thromboembolism.
Martínez-González J; Vila L; Rodríguez C
Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):793-802. PubMed ID: 18570617
[TBL] [Abstract][Full Text] [Related]
11. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
MMW Fortschr Med; 2006 Jun; 148(23):58-9. PubMed ID: 16826742
[No Abstract] [Full Text] [Related]
12. [The prophylaxis against venous thromboembolic complications in internal medicine--the gap between theory and practice].
Hirmerová J
Vnitr Lek; 2006 Apr; 52(4):379-88. PubMed ID: 16755994
[TBL] [Abstract][Full Text] [Related]
13. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
Haas S
Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
Duhl AJ
J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotics and anticoagulants in coronary syndromes and stroke.
Turpie AG
Semin Thromb Hemost; 2000; 26 Suppl 1():79-83. PubMed ID: 11011811
[TBL] [Abstract][Full Text] [Related]
16. Prevention of venous thromboembolism in hospitalized medical patients.
Lenchus JD; Jaffer AK
Mt Sinai J Med; 2008 Oct; 75(5):449-53. PubMed ID: 18828167
[TBL] [Abstract][Full Text] [Related]
17. [Low molecular weight heparin--1998 status].
Marbet GA
Praxis (Bern 1994); 1999 Apr; 88(18):802-7. PubMed ID: 10409877
[TBL] [Abstract][Full Text] [Related]
18. Low- and ultra-low-molecular-weight heparins.
Kakkar AK
Best Pract Res Clin Haematol; 2004 Mar; 17(1):77-87. PubMed ID: 15171959
[TBL] [Abstract][Full Text] [Related]
19. [Non-fractionated heparin versus low molecular weight heparin in acute coronary syndromes].
González Pacheco H
Arch Cardiol Mex; 2001; 71 Suppl 1():S63-8. PubMed ID: 11565348
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies.
ten Cate-Hoek AJ; Prins MH
Thromb Res; 2008; 122(5):584-98. PubMed ID: 17996281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
